Your browser doesn't support javascript.
loading
Long-term prognostic value of the GenesWell BCT score in Asian women with hormone receptor-positive/HER2-negative early breast cancer.
Fujiki, Yoshitaka; Kashiwaba, Masahiro; Sato, Mutsumi; Kawano, Junko; Teraoka, Megumi; Kanemitsu, Shuichi; Rai, Yoshiaki; Taira, Tetsuhiko; Sagara, Yoshiaki; Ohi, Yasuyo; Jo, Uiree; Lee, Young-Won; Lee, Sae Byul; Gong, Gyungyub; Shin, Young Kee; Kwon, Mi Jeong; Sagara, Yasuaki.
Afiliação
  • Fujiki Y; Department of Breast and Endocrine Surgical Oncology, Hakuaikai Social Medical Corporation, Sagara Hospital, 3-28 Matsubara, Kagoshima, 892-0098, Japan.
  • Kashiwaba M; Department of Breast and Endocrine Surgical Oncology, Hakuaikai Social Medical Corporation, Sagara Hospital, 3-28 Matsubara, Kagoshima, 892-0098, Japan.
  • Sato M; Department of Breast and Endocrine Surgical Oncology, Hakuaikai Social Medical Corporation, Sagara Hospital, 3-28 Matsubara, Kagoshima, 892-0098, Japan.
  • Kawano J; Department of Breast and Endocrine Surgical Oncology, Hakuaikai Social Medical Corporation, Sagara Hospital, 3-28 Matsubara, Kagoshima, 892-0098, Japan.
  • Teraoka M; Department of Breast and Endocrine Surgical Oncology, Hakuaikai Social Medical Corporation, Sagara Hospital, 3-28 Matsubara, Kagoshima, 892-0098, Japan.
  • Kanemitsu S; Department of Breast and Endocrine Surgical Oncology, Hakuaikai Social Medical Corporation, Sagara Hospital, 3-28 Matsubara, Kagoshima, 892-0098, Japan.
  • Rai Y; Department of Breast and Endocrine Surgical Oncology, Hakuaikai Social Medical Corporation, Sagara Hospital, 3-28 Matsubara, Kagoshima, 892-0098, Japan.
  • Taira T; Department of Medical Oncology, Hakuaikai Social Medical Corporation, Sagara Hospital, Kagoshima, Japan.
  • Sagara Y; Department of Radiology, Hakuaikai Social Medical Corporation, Sagara Hospital, Kagoshima, Japan.
  • Ohi Y; Department of Pathology, Hakuaikai Social Medical Corporation, Sagara Hospital, Kagoshima, Japan.
  • Jo U; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
  • Lee YW; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
  • Lee SB; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
  • Gong G; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
  • Shin YK; Laboratory of Molecular Pathology and Cancer Genomics, Research Institute of Pharmaceutical Sciences and College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
  • Kwon MJ; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Republic of Korea.
  • Sagara Y; Vessel-Organ Interaction Research Center, College of Pharmacy, Kyungpook National University, 80 Daehak-Ro, Buk-Gu, Daegu, 41566, Republic of Korea. mjkwon94@knu.ac.kr.
Breast Cancer ; 31(1): 31-41, 2024 Jan.
Article em En | MEDLINE | ID: mdl-37812303
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Breast Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Breast Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão